Bd Diagnostics (Geneohm Sciences, Inc.)

Bd Diagnostics (Geneohm Sciences, Inc.) — FDA 510(k) Submissions

Bd Diagnostics (Geneohm Sciences, Inc.) has submitted 2 FDA 510(k) premarket notifications since 2008, of which 2 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Reagents, Clostridium Difficile Toxin, System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen . Use the specialty filter in the sidebar to narrow results.